Who has invested in Wild Bioscience?

Oxford Science Enterprises, Braavos Capital are named among the investors backing Wild Bioscience.

Wild Bioscience Funding: $60M Raised, Series A (2025)

Wild Bioscience funding overview

Wild Bioscience is based in Oxford, United Kingdom. Wild Bioscience has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2025. The round record for Wild Bioscience runs through 2025; nothing later has been disclosed. Investors on record include Oxford Science Enterprises, Braavos Capital. 2 distinct backers are named across the disclosed rounds.

Wild Bioscience at a glance

Total raised: $60M
Latest round: Series A
Latest round date: October 2025
Headquarters: Oxford, United Kingdom
Notable investors: Oxford Science Enterprises, Braavos Capital

Frequently asked about Wild Bioscience funding

How much has Wild Bioscience raised?: Wild Bioscience has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Wild Bioscience?: Oxford Science Enterprises, Braavos Capital are named among the investors backing Wild Bioscience.
What was the latest Wild Bioscience funding round?: The most recent disclosed round is a Series A, announced in October 2025.
Where is Wild Bioscience based?: Wild Bioscience is based in Oxford, United Kingdom.
When did Wild Bioscience last raise?: The last disclosed Wild Bioscience round closed in October 2025 at Series A.

We update the Wild Bioscience record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Oxford and their backers are listed below.

Wild Bioscience Funding: $60M Raised, Series A (2025)

Wild Bioscience funding overview

Wild Bioscience at a glance

Frequently asked about Wild Bioscience funding

Companies related to Wild Bioscience (27)

Browse related funding lists (4)